What Happened?
San Diego, CA-based Poseida Appointed Kelly Cicchelli as Director Total Rewards
About the Company
Poseida Therapeutics is a clinical-stage biotechnology company translating best-in-class technology into lifesaving cell and gene therapies for patients with high unmet medical need. The company is developing CAR T-cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as in vivo gene therapies for orphan genetic diseases. These cell therapies and the gene therapies soon to come are products of our proprietary suite of industry-leading gene engineering technologies, including the piggyBac® DNA Modification System, Cas-CLOVER™ and TAL-CLOVER™ site-specific nucleases.
About the Person
Kelly Cicchelli is Director Total Rewards at Poseida. Previously, Kelly held various senior HR leadership roles in the industry.
Info Source
News
Short Profile